Coordinating Multidisciplinary Cancer Care

Documents to Request

• Tumor board recommendation with treatment plan and sequencing
• NCCN guideline timing recommendations for the specific cancer type and stage
• Surgical scheduling availability and pre-operative requirements
• Medical oncology treatment plan with planned start date and cycle schedule
• Radiation oncology consultation with planned simulation and start date
• Pre-treatment workup results (staging, organ function, cardiac clearance)
• Patient insurance authorization status for each modality
• Clinical trial protocol with mandated timelines if applicable

Step 1: Map the Treatment Sequence per Evidence-Based Guidelines

Common multimodal sequencing paradigms:

For each treatment component, document the planned start date, expected duration, and the interval to the next component.

Step 2: Identify and Mitigate Time-Critical Gaps

Common causes of treatment delays:

Track each potential delay with a responsible party and resolution date.

Step 3: Create the Coordinated Treatment Timeline

Build a visual treatment timeline documenting:

1. Week 0: Diagnosis date and tumor board presentation date
2. Pre-treatment phase: All required workup, authorizations, port placement, dental clearance (for H&N RT), fertility preservation, prehabilitation
3. Treatment Phase 1: First modality with start date, cycle schedule, expected end date
4. Restaging (if applicable): Imaging and assessment between neoadjuvant and surgical phases
5. Treatment Phase 2: Second modality with start date determined by recovery interval
6. Treatment Phase 3: Third modality with start date
7. Post-treatment: First surveillance visit, survivorship care plan delivery

Example timeline — Locally advanced rectal cancer:

• Week 0: Diagnosis, staging, tumor board
• Week 1–2: Pre-treatment workup, port placement, RT simulation
• Week 3–8: Concurrent capecitabine + 50.4 Gy RT (28 fractions)
• Week 14–16: Restaging MRI, interval assessment
• Week 16–18: Surgical resection (TME)
• Week 22–24: Adjuvant chemotherapy initiation (FOLFOX or CAPOX)
• Week 22–46: Adjuvant chemotherapy (4 months total perioperative)

Step 4: Establish Communication and Accountability Framework

1. Designate a care coordinator responsible for tracking the treatment timeline
2. Establish communication channels: all treating specialists should receive the complete treatment plan with timeline
3. Create milestone checkpoints:
   • Pre-treatment checklist complete → clear to start treatment
   • Post-neoadjuvant restaging → surgical planning meeting
   • Post-surgery recovery confirmed → medical oncology clearance to start adjuvant
   • Treatment completion → survivorship care plan handoff
4. Patient communication: provide the patient with a written treatment calendar showing appointments, treatment dates, and expected milestones
5. Escalation protocol: define who is contacted when a delay is identified and the maximum acceptable delay before re-evaluation

Checkpoint B: Post-Draft Alignment (Mandatory)

1. Does the treatment sequence match the NCCN guideline recommendation for this cancer type and stage?
2. Are all time-critical intervals identified with target dates and maximum acceptable delays?
3. Is each treatment modality assigned to a named specialist with a planned start date?
4. Have potential delay risks been identified with mitigation strategies?
5. Is the patient informed of the treatment timeline with a written calendar?

Quality Audit

• Tumor board recommendation documented with treatment plan and sequencing
• Treatment sequence matches NCCN guideline for the cancer type and stage
• Time-critical intervals identified per evidence-based guidelines
• Each modality has a named treating specialist and planned start date
• Pre-treatment workup checklist complete with all results documented
• Insurance prior authorization obtained or in progress for each modality
• Potential delays identified with mitigation strategies and responsible parties
• Treatment timeline created with milestone checkpoints
• All specialists have received the complete treatment plan
• Patient navigator or care coordinator assigned
• Patient provided written treatment calendar
• Diagnosis-to-treatment interval tracked against benchmark (<4 weeks for most cancers)
• No treatment component scheduled without confirmation from the preceding specialist that the patient is cleared

Guidelines

• Treatment delays are the most common preventable quality failure in cancer care — track time from diagnosis to first treatment as a key metric
• The diagnosis-to-treatment interval should not exceed 4 weeks for most solid tumors (exceptions: watchful waiting for low-risk prostate, surveillance for early CLL)
• Never start the next treatment phase without documented clearance from the specialist managing the preceding phase (e.g., surgeon confirms adequate wound healing before starting adjuvant chemo)
• Head and neck radiation should not be interrupted — every day of treatment prolongation beyond the planned schedule reduces local control by approximately 1.4% per day
• For concurrent chemoradiation, chemotherapy and radiation must start simultaneously — do not delay radiation to "complete a full cycle" of chemotherapy first
• Molecular testing should be ordered at diagnosis, not after treatment failure — turnaround time can be 2–3 weeks and delays targeted therapy initiation
• Fertility preservation counseling must occur before treatment initiation — it cannot be done after gonadotoxic therapy begins
• Patient navigation reduces treatment delays by 30–50% in underserved populations — advocate for navigator assignment for complex multimodal plans